Updated Guidelines for Managing Drug Interactions in the Treatment of HIV-Related TB


These updated guidelines from the CDC include recommendations for newer antiretroviral drugs, including those in new classes, as well as recommendations regarding use of rifampin with antiretroviral therapy. The publication provides summaries of clinical experience with use of specific antiretroviral regimens during TB treatment, a table summarizing clinical experience with key antiretroviral regimens and recommended regimens, and sections addressing treatment for people with latent TB infection, pediatric patients, pregnant women, and patients with drug-resistant TB.